Esperion Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Esperion Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2012 to Q1 2024.
  • Esperion Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $14M, a 2.52% decline year-over-year.
  • Esperion Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $58.6M, a 2.59% increase year-over-year.
  • Esperion Therapeutics, Inc. annual Interest Expense for 2023 was $59M, a 3.81% increase from 2022.
  • Esperion Therapeutics, Inc. annual Interest Expense for 2022 was $56.8M, a 22.6% increase from 2021.
  • Esperion Therapeutics, Inc. annual Interest Expense for 2021 was $46.4M, a 104% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $58.6M $14M -$363K -2.52% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $59M $15.1M +$728K +5.08% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $58.2M $15M +$842K +5.95% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $57.4M $14.5M +$271K +1.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $57.1M $14.4M +$325K +2.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $56.8M $14.3M +$899K +6.69% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $55.9M $14.2M +$499K +3.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $55.4M $14.3M +$3.12M +28% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $52.3M $14.1M +$5.94M +73.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $46.4M $13.4M +$4.5M +50.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-21
Q3 2021 $41.9M $13.7M +$8.73M +177% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $33.1M $11.1M +$6.5M +140% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $26.6M $8.13M +$3.95M +94.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $22.7M $8.93M +$4.81M +117% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-23
Q3 2020 $17.9M $4.93M +$932K +23.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $16.9M $4.64M +$4.64M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $12.3M $4.17M +$4.17M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $8.12M $4.12M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 $4M Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2017 $198K $32K -$46K -59% Oct 1, 2017 Dec 31, 2017 10-K 2018-02-20
Q3 2017 $244K $44K -$45K -50.6% Jul 1, 2017 Sep 30, 2017 10-K 2018-02-20
Q2 2017 $289K $55K -$44K -44.4% Apr 1, 2017 Jun 30, 2017 10-K 2018-02-20
Q1 2017 $333K $67K -$43K -39.1% Jan 1, 2017 Mar 31, 2017 10-K 2018-02-20
Q4 2016 $376K $78K -$43K -35.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-20
Q3 2016 $419K $89K -$41K -31.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-20
Q2 2016 $460K $99K -$36K -26.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-20
Q1 2016 $496K $110K -$24K -17.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-20
Q4 2015 $520K $121K -$13K -9.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-22
Q3 2015 $533K $130K -$5K -3.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-22
Q2 2015 $538K $135K +$134K Apr 1, 2015 Jun 30, 2015 10-K 2017-02-22
Q1 2015 $404K $134K Jan 1, 2015 Mar 31, 2015 10-K 2017-02-22
Q4 2014 $134K Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $135K Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $1K* -$107K Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q2 2013 $1.86M $108K -$195K -64.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-10
Q1 2013 $2.05M $828K +$568K +218% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-10
Q4 2012 $1.49M $562K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 $361K Jul 1, 2012 Sep 30, 2012 10-K 2014-03-13
Q2 2012 $303K Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 $260K Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.